MASHINIi

NANO-X IMAGING LTD.

NNOX.US | Manufacture of irradiation, electromedical and electrotherapeutic equipment

Nano-X Imaging Ltd. is an innovative medical imaging technology company focused on transforming global healthcare by making advanced medical imaging more accessible and affordable. The company has developed a novel digital X-ray source, based on microelectromechanical systems (MEMS) technology, desi...Show More

Ethical Profile

Mixed.

NANO-X IMAGING LTD aims to make medical imaging accessible, especially in underserved regions, with its FDA-cleared Nanox.ARC X system, priced between $60,000-$80,000. It offers 3D imaging and remote interpretation via Nanox.CLOUD. However, the company reported a Q4 2024 GAAP net loss of $14.1 million and negative gross profit margins. NANO-X also faced a $650,000 SEC fine related to development cost estimates and settled an $8 million shareholder class action. The company maintains a whistleblower policy and code of ethics.

Value Scores

Better Health for All40
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-30
-100100
Kind to Animals10
-100100
No War, No Weapons-40
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

40

Nano-X Imaging's core products, the Nanox.ARC and Nanox.AI suite, are designed to deliver revolutionary health benefits by improving early detection, diagnostic accuracy, and reducing radiation exposure by 30-95%.

1
The company's entire portfolio is dedicated to these health-positive outcomes, resulting in no revenue from harmful products since inception.
2
The Nanox.ARC X system is priced at $60,000-$80,000,
3
significantly lower than traditional CT scanners costing millions,
4
and its pay-per-scan model further enhances affordability.
5
This cost-effectiveness, combined with its design for rural clinics and underserved regions, aims to reach 90-95% of vulnerable populations. The company's R&D expenses were $5.0 million in Q1 2025,
6
representing 166% of its $3.0 million revenue for the same quarter,
7
indicating a substantial investment in health innovation. Nanox AI solutions are explicitly designed to enable preventive care before symptoms appear,
8
driving a transition to preventive healthcare.
9
However, the company faces ethical challenges regarding algorithmic bias and data privacy,
10
with a stated objective to ingest, structure, and anonymize over 2 million new images,
11
and a need to ensure compliance with GDPR and HIPAA.
12
The company's products also enhance patient safety by reducing radiation exposure by 30-95%
13
and feature a cable-free design to reduce tripping hazards.
14

Fair Money & Economic Opportunity

0

Nano-X Imaging Ltd. is a medical imaging technology company focused on developing and deploying digital X-ray systems and cloud-based infrastructure for medical imaging services.

1
Its business model involves providing systems and generating revenue through pay-per-scan services. The company does not engage in activities related to lending, insuring, moving, or storing money, nor does it offer financial products or services to consumers.
2
Therefore, all KPIs under the 'Fair Money & Economic Opportunity' value are not applicable, and no relevant evidence could be extracted from the provided articles.
3

Fair Pay & Worker Respect

0

No evidence available to assess NANO-X IMAGING LTD on Fair Pay & Worker Respect.

Fair Trade & Ethical Sourcing

0

No evidence available to assess NANO-X IMAGING LTD on Fair Trade & Ethical Sourcing.

Honest & Fair Business

-30

Nano-X Imaging Ltd. incurred a $650,000 SEC fine related to an investigation into development and assembly cost estimates for Nanox.ARC, which the company and its former Chairman settled.

1
The company has a whistleblower policy, established in January 2023, which includes a confidential and anonymous hotline and web form for reporting accounting or auditing matters.
2
The Audit Committee is responsible for receiving and addressing these complaints and following up with complainants, but there is no evidence of independent investigation processes.
3

Kind to Animals

10

The company has a stated "No Animal Testing" policy.

1
This indicates a global corporate ban on animal testing, aligning with a score of 100 for `animal_testing_policy`. Given the company's business model as a medical imaging technology and service provider, there is no evidence of operations involving animal-derived products, animal husbandry, or direct impact on wildlife habitats. Therefore, KPIs such as `cruelty_free_cert_share`, `alt_testing_usage`, `humane_cert_ops_pct`, `wildlife_conservation_impact`, `ethical_input_sub_pct`, `supplier_audit_pct`, `cage_free_source_pct`, `innovation_investment_pct`, `animal_agriculture_ethics`, `animal_free_rd_collaboration`, and `public_policy_engagement` are not applicable, resulting in a score of 0 (N/A) for these metrics. For `animal_testing_volume`, the "No Animal Testing" policy means no animals are used, which maps to N/A (0) as per the rubric.

No War, No Weapons

-40

The company entered into MSaaS agreements in 2020 with JSC Roel Group in the Russian Federation for $12.6 million and with Clarity Medical Solution in Belarus for $3.7 million.

1
No other information regarding sales to embargoed regimes, dual-use technologies, or peacebuilding initiatives was found.
2

Planet-Friendly Business

0

The provided articles do not contain specific quantitative data points for any of the 'Planet-Friendly Business' KPIs.

1
Information regarding environmental performance, such as greenhouse gas emissions, renewable energy use, water consumption, waste diversion, or climate targets, is not available.
2
The articles explicitly state a lack of relevant sustainability metrics for Nano-X Imaging Ltd.
3

Respect for Cultures & Communities

0

The company has a 'Controversy Level' of 'None', indicating no reported cultural appropriation incidents.

1

Safe & Smart Tech

0

The company's privacy policy outlines data subject rights, including access, correction, deletion, and data portability, and provides mechanisms for users to opt-out of targeted advertising and profiling.

1
A data subject request form is available for exercising these rights under various US privacy laws (CCPA, VCDPA, CPA, CTDPA, UCPA, OCPA, MCDPA, TDPSA, FDBR) and GDPR/UK GDPR.
2
The privacy policy states that data is retained only as necessary for stated purposes, subject to legal requirements.
3
The company mentions compliance with GDPR and other data protection laws, including specific provisions for EU and UK data transfers.
4

Zero Waste & Sustainable Products

0

The company has no mentioned waste disposal violations, regulatory actions, fines, or compliance issues in the provided articles.

1

Own NANO-X IMAGING LTD?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.